News & events

  • Pascale Bouillé, CEO of Vectalys and president at FlashCell, was at the "Bioproduction des immunothérapies en France" conference at Biocitech Romainville on 09-26-2017 to talk about our new generation of RNA delivery particle and its applications in gene editing and immunotherapy.
  • News
    The FlashCell team looks forward to sharing its recent data about LentiFlash™ for genome-editing and immunotherapy approaches at the ESGCT 2017.
  • Vectalys is proud to launch FlashCell, a new gene therapy company specialized in the development of RNA carriers for therapeutic applications.